Wim Vandenberghe
Wim is an EU life sciences partner in Reed Smith’s Brussels office.
He helps pharmaceuticals, biotech and medtech companies navigate the regulatory process in Europe throughout the life cycle of their products. This includes advising clients on a broad range of issues such as regulatory pathway, marketing authorizations, CE marking, clinical trials, GxP/QMS requirements, internal compliance policies, advertising and promotion, HCP/HCO interactions.
As natural corollary of his regulatory practice, Wim has developed substantial experience in drafting, reviewing and negotiating industry contracts.
Wim has been recognized by Legal 500 on its 2023 list of notable EU Regulatory: Pharma, Medical Devices and Biotech practices.